SCHEDULE OF WARRANT ACTIVITY (Details) - $ / shares |
9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Equity [Abstract] | ||||
| Warrants Outstanding, Beginning balance | 13,086,220 | 6,718,176 | 6,718,176 | |
| Weighted Average Exercise Price, Beginning balance | $ 1.92 | $ 2.37 | $ 2.37 | |
| Weighted Average Remaining Contractual Term in Years | 3 years 10 days | 4 years 4 months 9 days | 3 years 9 months 10 days | 4 years 6 months 21 days |
| Warrants, Issued | 3,644,299 | |||
| Weighted Average Exercise Price, Issued | $ 1.65 | |||
| Warrants, Exercised | (659,786) | |||
| Weighted Average Exercise Price, Exercised | $ 1.37 | |||
| Warrants, Expired | ||||
| Weighted Average Exercise Price, Expired | ||||
| Warrants Outstanding, Ending balance | 13,086,220 | 9,702,689 | 13,086,220 | 6,718,176 |
| Weighted Average Exercise Price, Ending balance | $ 1.92 | $ 2.06 | $ 1.92 | $ 2.37 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments expirations in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|